Literature DB >> 4751256

Protection with N-acetyl-L-cysteine (NSC-111180) against isophosphamide (NSC-109724) toxicity and enhancement of therapeutic effect in early murine L1210 leukemia.

I Kline, M Gang, R J Woodman, R L Cysyk, J M Venditti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4751256

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  7 in total

1.  Cyclophosphamide-induced cystitis of the urinary bladder of rats and its treatment.

Authors:  D A Tolley; J E Castro
Journal:  Proc R Soc Med       Date:  1975-03

2.  [On the binding of cyclophosphamide and cyclophosphamide-metabolites to serum-albumin (author's transl)].

Authors:  G Voelcker; H P Giera; L Jäger; H J Hohorst
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-05-31

3.  Antimutagens. Data and problems.

Authors:  E Gebhart
Journal:  Humangenetik       Date:  1974

4.  Influence of mesna and cysteine on the systemic toxicity and therapeutic efficacy of activated cyclophosphamide.

Authors:  T Wagner; M Zink; G Schwieder
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

5.  Comparative studies on the specificity of anticlastogenic action in human lymphocytes in culture.

Authors:  E Gebhart; R Becher
Journal:  Hum Genet       Date:  1976-04-15       Impact factor: 4.132

6.  Potentiation of chemotherapeutics by bromelain and N-acetylcysteine: sequential and combination therapy of gastrointestinal cancer cells.

Authors:  Afshin Amini; Samar Masoumi-Moghaddam; Anahid Ehteda; Winston Liauw; David Lawson Morris
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

7.  Direct search methods in the optimisation of cancer chemotherapy regimens.

Authors:  M C Berenbaum
Journal:  Br J Cancer       Date:  1990-01       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.